GlassScriptPhysician profile
Eric C Liberman
NPI 1780818146
$16,764.39
in general payments reported to CMS, 2019-2025
27 companies · $7,626 in 2025
The $7,626 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,485 · 2023: $4,038 · 2024: $3,616 · 2025: $7,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,500 · Honoraria: $4,750 · Food and Beverage: $1,938 · Travel and Lodging: $1,092 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,500.00 |
| Honoraria | $4,750.00 |
| Food and Beverage | $1,937.86 |
| Travel and Lodging | $1,091.79 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Richard Wolf Medical Instruments Corp. | $11,313.24 | 2023-2025 | |
| Intuitive Surgical, INC. | $2,529.81 | 2025 | |
| Momentis Surgical INC. | $1,123.00 | 2022 | |
| Hologic Sales and Service, LLC | $511.40 | 2023-2024 | Acessa Provu System, Coolseal Generator, Fluent Fluid Management System |
| Gynesonics, INC. | $147.88 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Boston Scientific Corporation | $108.97 | 2022 | |
| Merck Sharp & Dohme LLC | $108.10 | 2022-2025 | Lynparza, Keytruda |
| Davol INC. | $105.59 | 2024-2025 | Channel Drain, Arista |
| Abbvie INC. | $91.82 | 2022-2025 | |
| Pfizer INC. | $86.25 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $76.50 | 2023-2024 | Myfembree |
| Applied Medical Resources Corporation | $72.62 | 2022 | |
| Mayne Pharma Commercial LLC | $69.73 | 2025 | |
| Myriad Genetic Laboratories, INC. | $54.92 | 2022-2024 | Precisetumor |
| Glaxosmithkline, LLC. | $51.57 | 2022-2025 | Jemperli, Zejula |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $47.53 | 2022-2024 | Harmonic, Stratafix, Vistaseal |
| Mimedx Group, INC. | $43.90 | 2025 | |
| Tempus Ai, INC | $42.60 | 2024-2025 | Xt Cdx |
| Cumberland Pharmaceuticals, INC. | $34.11 | 2024 | Caldolor |
| Olympus America INC. | $28.57 | 2024 | Olympus |
| Meditrina | $21.66 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.18 | 2025 | |
| Amgen INC. | $18.00 | 2025 | Evenity |
| Avion Pharmaceuticals | $15.08 | 2022 | |
| Minerva Surgical, INC | $14.67 | 2025 | |
| Immunogen, INC. | $13.81 | 2024 | Elahere |
| Therapeuticsmd, INC. | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Liberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.